European Archives - Page 39 of 1095 - European Medical Journal

Does the Gut Microbiome Influence the Efficacy of Psychiatric Drugs?

Altered gut microbiome profiles correlate with anxiety and depression in humans, and work in animal models has identified specific…

Systemic Health Impact of Leaky Barriers in the Oral-Gut-Brain Axis

The human body is a holistic system, interconnected by the circulatory, nervous, lymphatic, endocrine, and immune systems that facilitate…

Intersection of the Upper Gastrointestinal Microbiome and Oesophageal Cancer

The upper gastrointestinal microbiome, a complex ecosystem of microorganisms that have historically been difficult to identify, may play a…

Infliximab-Induced Multifocal Motor Neuropathy

Multifocal motor neuropathy (MMN) is a rare immune-mediated disorder characterised by progressive, asymmetric muscle weakness…

Rare Anti-HMGCR-Induced Immune-Mediated Necrotising Myopathy

An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of weakness affecting…

Peritoneal Tuberculosis in the Guise of Ovarian Carcinoma

Peritoneal tuberculosis (TB) is a form of extrapulmonary TB that primarily affects areas such as the omentum, liver…

Can Time-Restricted Feeding Improve MAFLD Management?

Time-restricted feeding (TRF), limits food intake to a set daily window, such as the 16:8 model.

The World’s First Autonomous AI Skin Cancer Detector Approved for Use in Europe

World-first AI for skin cancer detection approved in Europe, cutting wait times and outperforming dermatologists with 99.8% accuracy.

Tackling bias, driving change: A roundtable for International Women’s Day

How can the pharmaceutical industry ‘Accelerate Action’ on gender parity this International Women’s Day? Find out now.

Obesity Hampers Gout Therapy Success, Raising Gout Flare Risks

Obesity significantly diminishes the effectiveness of urate-lowering therapy in male gout patients, according to a new study. Only 38.9% of obese patients achieved target serum urate levels compared to 63.8% of normal-weight patients, highlighting the need for integrated weight management in gout treatment.